PIH1D2
geneOn this page
Also known as DNAAF15
Summary
PIH1D2 (PIH1 domain containing 2, HGNC:25210) is a protein-coding gene on chromosome 11q23.1, encoding PIH1 domain-containing protein 2 (Q8WWB5).
Enables small GTPase binding activity. Predicted to be involved in box C/D snoRNP assembly and rRNA processing. Part of protein folding chaperone complex.
Source: NCBI Gene 120379 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 42 total
- MANE Select transcript:
NM_138789
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25210 |
| Approved symbol | PIH1D2 |
| Name | PIH1 domain containing 2 |
| Location | 11q23.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DNAAF15 |
| Ensembl gene | ENSG00000150773 |
| Ensembl biotype | protein_coding |
| Entrez | 120379 |
Gene structure
Transcript identifiers
Ensembl transcripts: 13 — 10 protein_coding, 1 protein_coding_CDS_not_defined, 1 non_stop_decay, 1 nonsense_mediated_decay
ENST00000280350, ENST00000431456, ENST00000521853, ENST00000525072, ENST00000525744, ENST00000528775, ENST00000530641, ENST00000532211, ENST00000676994, ENST00000957365, ENST00000957366, ENST00000957367, ENST00000957368
RefSeq mRNA: 2 — MANE Select: NM_138789
NM_001082619, NM_138789
CCDS: CCDS44730, CCDS8355
Canonical transcript exons
ENST00000280350 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000996266 | 112071038 | 112071283 |
| ENSE00000996267 | 112070436 | 112070701 |
| ENSE00001130661 | 112072998 | 112073205 |
| ENSE00001557660 | 112073980 | 112074017 |
| ENSE00002140408 | 112067798 | 112068005 |
| ENSE00003558721 | 112071635 | 112071758 |
Expression profiles
Bgee: expression breadth ubiquitous, 174 present calls, max score 94.40.
FANTOM5 (CAGE): breadth broad, TPM avg 1.5980 / max 99.7491, expressed in 735 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 122304 | 1.5526 | 716 |
| 122305 | 0.0454 | 9 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 94.40 | gold quality |
| right testis | UBERON:0004534 | 94.10 | gold quality |
| right uterine tube | UBERON:0001302 | 92.86 | gold quality |
| testis | UBERON:0000473 | 92.10 | gold quality |
| bronchial epithelial cell | CL:0002328 | 91.59 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.51 | gold quality |
| bronchus | UBERON:0002185 | 89.49 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.35 | gold quality |
| sperm | CL:0000019 | 85.47 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.47 | gold quality |
| adult organism | UBERON:0007023 | 84.71 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 81.09 | gold quality |
| fallopian tube | UBERON:0003889 | 76.11 | gold quality |
| oviduct epithelium | UBERON:0004804 | 75.71 | gold quality |
| adenohypophysis | UBERON:0002196 | 75.62 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 74.58 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 74.06 | gold quality |
| thyroid gland | UBERON:0002046 | 73.85 | gold quality |
| pituitary gland | UBERON:0000007 | 73.41 | gold quality |
| islet of Langerhans | UBERON:0000006 | 72.62 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.51 | gold quality |
| hypothalamus | UBERON:0001898 | 71.04 | gold quality |
| ventricular zone | UBERON:0003053 | 70.94 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 70.42 | gold quality |
| right lung | UBERON:0002167 | 70.32 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 69.57 | gold quality |
| caudate nucleus | UBERON:0001873 | 69.37 | gold quality |
| calcaneal tendon | UBERON:0003701 | 69.13 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 69.04 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 68.88 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.85 |
| E-MTAB-9388 | yes | 7.01 |
| E-GEOD-36552 | no | 50.25 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pih1d2 | ENSDARG00000014849 |
| mus_musculus | Pih1d2 | ENSMUSG00000000167 |
| rattus_norvegicus | Pih1d2 | ENSRNOG00000009965 |
| drosophila_melanogaster | CG4022 | FBGN0035986 |
Paralogs (2): PIH1D1 (ENSG00000104872), DNAAF2 (ENSG00000165506)
Protein
Protein identifiers
PIH1 domain-containing protein 2 — Q8WWB5 (reviewed: Q8WWB5)
All UniProt accessions (3): Q8WWB5, A0A0A0MTE1, H0YCC0
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. May be due to a competing donor splice site.
Similarity. Belongs to the PIH1 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8WWB5-1 | 1 | yes |
| Q8WWB5-2 | 2 | |
| Q8WWB5-3 | 3 |
RefSeq proteins (2): NP_001076088, NP_620144* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012981 | PIH1_N | Domain |
| IPR041442 | PIH1D1/2/3_CS-like | Domain |
| IPR050734 | PIH1/Kintoun_subfamily | Family |
Pfam: PF08190, PF18201
UniProt features (6 total): splice variant 4, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WWB5-F1 | 78.27 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 111 (showing top):
GOBP_RIBOSOME_BIOGENESIS, GOMF_GTPASE_BINDING, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_PROTEIN_STABILIZATION, GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION, GOBP_REGULATION_OF_PROTEIN_STABILITY, RYTTCCTG_ETS2_B, RFX1_02, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, CETS1P54_01, GOCC_RIBONUCLEOPROTEIN_COMPLEX, SCGGAAGY_ELK1_02, DODD_NASOPHARYNGEAL_CARCINOMA_DN, ELK1_02, CHYLA_CBFA2T3_TARGETS_DN
GO Biological Process (3): box C/D snoRNP assembly (GO:0000492), rRNA processing (GO:0006364), protein stabilization (GO:0050821)
GO Molecular Function (2): small GTPase binding (GO:0031267), protein binding (GO:0005515)
GO Cellular Component (4): cytoplasm (GO:0005737), R2TP complex (GO:0097255), protein folding chaperone complex (GO:0101031), ribonucleoprotein complex (GO:1990904)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein-containing complex | 2 |
| small nucleolar ribonucleoprotein complex assembly | 1 |
| RNA processing | 1 |
| rRNA metabolic process | 1 |
| ribosome biogenesis | 1 |
| regulation of protein stability | 1 |
| GTPase binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular protein-containing complex | 1 |
Protein interactions and networks
STRING
762 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PIH1D2 | SPAG1 | Q07617 | 831 |
| PIH1D2 | DNAAF6 | Q9NQM4 | 830 |
| PIH1D2 | RUVBL1 | P82276 | 786 |
| PIH1D2 | RUVBL2 | Q9Y230 | 782 |
| PIH1D2 | RPAP3 | Q9H6T3 | 761 |
| PIH1D2 | DNAI1 | Q9UI46 | 633 |
| PIH1D2 | DNAAF10 | Q96MX6 | 623 |
| PIH1D2 | CFAP300 | Q9BRQ4 | 591 |
| PIH1D2 | DNAAF2 | Q9NVR5 | 591 |
| PIH1D2 | LRRC56 | Q8IYG6 | 590 |
| PIH1D2 | DNAAF4 | Q8WXU2 | 587 |
| PIH1D2 | NKAPD1 | Q6ZUT1 | 572 |
| PIH1D2 | HSP90AB1 | P08238 | 567 |
| PIH1D2 | HSP90AA1 | P07900 | 565 |
| PIH1D2 | DNALI1 | O14645 | 564 |
IntAct
253 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PIH1D2 | KRTAP12-4 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PIH1D2 | MRFAP1L1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MDFI | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PIH1D2 | DPH3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MRFAP1L1 | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP12-4 | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PIH1D2 | MDFI | psi-mi:“MI:0915”(physical association) | 0.720 |
| SPRED1 | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| GFAP | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| PIH1D2 | REL | psi-mi:“MI:0915”(physical association) | 0.670 |
| PIH1D2 | GFAP | psi-mi:“MI:0915”(physical association) | 0.670 |
| REL | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| ITGB3BP | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| EIF4A2 | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (77): PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), DPH3 (Two-hybrid), KRTAP12-4 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid), PIH1D2 (Two-hybrid)
ESM2 similar proteins: A0JMU5, A1A5P5, A3KN24, A6QLC7, A9ULH0, B2RXC1, B5DF07, B6DMK2, B6NXD5, O60678, O70467, O75417, P0C7N0, Q08B12, Q14AI0, Q19QT9, Q28ES8, Q2KI89, Q32LH3, Q32NV1, Q32PH0, Q3EBC8, Q4R6P2, Q5E9U4, Q5R629, Q5RDC7, Q5XGG3, Q5ZI89, Q5ZJM3, Q641F8, Q68F70, Q6DHJ1, Q6GMB0, Q6GPP1, Q6NU25, Q6PBV4, Q6PD74, Q7Z392, Q8BP74, Q8BSA9
Diamond homologs: B5BUZ8, B6F1W5, Q32LH3, Q5XGG3, Q7ZWY2, Q8WWB5, Q5PRB3, Q8CHR9
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| PIH1D2 | “form complex” | “R2SP co-chaperone” | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1033 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:112070517:A:AC | donor_gain | 0.9900 |
| 11:112070518:C:CC | donor_gain | 0.9900 |
| 11:112071296:T:TC | acceptor_gain | 0.9900 |
| 11:112070491:TTCA:T | donor_gain | 0.9800 |
| 11:112070499:A:AC | donor_gain | 0.9800 |
| 11:112070706:A:C | acceptor_gain | 0.9800 |
| 11:112071290:G:C | acceptor_gain | 0.9800 |
| 11:112071290:G:GC | acceptor_gain | 0.9800 |
| 11:112073759:TTCTC:T | donor_gain | 0.9800 |
| 11:112073760:T:TA | donor_gain | 0.9800 |
| 11:112073760:TCTCT:T | donor_gain | 0.9800 |
| 11:112070704:T:C | acceptor_gain | 0.9700 |
| 11:112070706:A:AC | acceptor_gain | 0.9700 |
| 11:112072993:CAT:C | donor_loss | 0.9700 |
| 11:112072994:AT:A | donor_loss | 0.9700 |
| 11:112072995:TAC:T | donor_loss | 0.9700 |
| 11:112072996:A:AT | donor_loss | 0.9700 |
| 11:112072997:C:CA | donor_loss | 0.9700 |
| 11:112070513:T:TA | donor_gain | 0.9600 |
| 11:112070702:C:CC | acceptor_gain | 0.9600 |
| 11:112071114:T:TA | donor_gain | 0.9600 |
| 11:112071203:A:C | donor_gain | 0.9600 |
| 11:112072991:GACAT:G | donor_loss | 0.9600 |
| 11:112072992:ACATA:A | donor_loss | 0.9600 |
| 11:112073893:A:C | donor_gain | 0.9600 |
| 11:112070704:T:TC | acceptor_gain | 0.9500 |
| 11:112072996:A:AC | donor_gain | 0.9500 |
| 11:112072997:C:CC | donor_gain | 0.9500 |
| 11:112071759:C:CC | acceptor_gain | 0.9400 |
| 11:112071036:ACC:A | donor_gain | 0.9300 |
AlphaMissense
2088 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:112071719:A:G | W73R | 0.973 |
| 11:112071719:A:T | W73R | 0.973 |
| 11:112067916:A:C | F301L | 0.964 |
| 11:112067916:A:T | F301L | 0.964 |
| 11:112067918:A:G | F301L | 0.964 |
| 11:112073129:A:G | W16R | 0.964 |
| 11:112073129:A:T | W16R | 0.964 |
| 11:112067924:C:G | A299P | 0.958 |
| 11:112067896:A:G | L308P | 0.953 |
| 11:112071259:G:T | A109D | 0.952 |
| 11:112067917:A:G | F301S | 0.945 |
| 11:112073127:C:A | W16C | 0.939 |
| 11:112073127:C:G | W16C | 0.939 |
| 11:112070449:A:G | L267P | 0.934 |
| 11:112067923:G:T | A299E | 0.932 |
| 11:112073122:A:G | L18P | 0.927 |
| 11:112070488:A:T | V254D | 0.926 |
| 11:112071729:G:C | N69K | 0.923 |
| 11:112071729:G:T | N69K | 0.923 |
| 11:112070482:A:G | L256S | 0.919 |
| 11:112071735:A:C | F67L | 0.917 |
| 11:112071735:A:T | F67L | 0.917 |
| 11:112071737:A:G | F67L | 0.917 |
| 11:112073077:A:G | F33S | 0.917 |
| 11:112073110:A:G | L22P | 0.913 |
| 11:112071717:C:A | W73C | 0.912 |
| 11:112071717:C:G | W73C | 0.912 |
| 11:112067968:A:G | L284S | 0.911 |
| 11:112071262:A:T | V108D | 0.910 |
| 11:112071260:C:G | A109P | 0.907 |
dbSNP variants (sampled 300 via entrez): RS1000299707 (11:112062615 G>A,T), RS1000411451 (11:112070192 T>C), RS1000856537 (11:112075312 C>T), RS1000864139 (11:112069820 C>A,T), RS1001475776 (11:112061686 C>A), RS1001581733 (11:112069708 G>A), RS1001985972 (11:112055109 T>C), RS1002032317 (11:112069223 G>A), RS1002775474 (11:112074499 C>A,G), RS1003044865 (11:112060699 C>T), RS1003096990 (11:112060230 C>G,T), RS1003399600 (11:112053486 T>A,C), RS1003632171 (11:112066041 A>G), RS1003753428 (11:112073320 G>C,T), RS1003784273 (11:112072910 T>A,G)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:245348
GenCC curated gene-disease
Mondo (1): pyruvate dehydrogenase E2 deficiency (MONDO:0009502)
Orphanet (2): Pyruvate dehydrogenase deficiency (Orphanet:765), Pyruvate dehydrogenase E2 deficiency (Orphanet:79244)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010703_266 | Brain morphology (MOSTest) | 4.000000e-13 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C565448 | Pyruvate Dehydrogenase E2 Deficiency (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| trichostatin A | affects expression | 1 |
| beta-lapachone | increases expression, decreases expression | 1 |
| bisphenol S | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | decreases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT05257005 | Not specified | UNKNOWN | Natural History Study of Pyruvate Dehydrogenase Deficiency |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): pyruvate dehydrogenase E2 deficiency